13F

Stock

Enanta Pharmaceuticals Inc

ENTA · held by 1 managers

Reported value

$192.3K

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$176.2K

Price effect on 1 books still in the name

Largest holder

$192.3K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC17.2K$192.3K−$176.2KCut−$897K

Positions as of Q3 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.